Loading...
 
Toggle Health Problems and D

COVID-19 mortality 3X more likely if low vitamin D (999,179 people) – meta-analysis March 29, 2021

Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis

Front. Nutr., 29 March 2021 https://doi.org/10.3389/fnut.2021.660420
Mohammad Rizki Akbar1*, Arief Wibowo1, Raymond Pranata1,2 and Budi Setiabudiawan3
1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
2Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
3Department of Child Health, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Image

VitaminDWiki

CDC says 26 health factors increase the risk of COVID-19 – all are associated with low vitamin D


Vitamin D meta-analyses for COVID-19


COVID-19 treated by Vitamin D - studies, reports, videos

As of July 24, the page had:  34 trials6 trial results,   20 meta-analyses and reviews,   61 observations,   34 recommendations,   53 associations,  89 speculations,  45 videos   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   26 risk factors are ALL associated with low Vit D,   Recent Virus pages   Fight COVID-19 with 50K Vit D weekly   Vaccine problems


Image
The above image is automatically updated

 Download the PDF from VitaminDWiki

Background: This systematic review and meta-analysis aimed to assess whether low serum 25-hydroxyvitamin D (25-OHD) level is associated with susceptibility to COVID-19, severity, and mortality related to COVID-19.

Methods: Systematic literature searches of PubMed, Scopus, and Embase database up until 9 December 2020. We include published observational prospective and retrospective studies with information on 25-OHD that reported main/secondary outcome. Low serum 25-OHD refers to participants with serum 25-OHD level below a cut-off point ranging from 20 to 30 ng/mL. Other cut-off values were excluded to reduce heterogeneity. The main outcome was mortality defined as non-survivor/death. The secondary outcome was susceptibility and severe COVID-19.

Results: There were 14 studies comprising of 999,179 participants. Low serum 25-OHD was associated with

  • higher rate of COVID-19 infection compared to the control group (OR = 2.71 [1.72, 4.29], p < 0.001; I2: 92.6%).
  • Higher rate of severe COVID-19 was observed in patients with low serum 25-OHD (OR = 1.90 [1.24, 2.93], p = 0.003; I2: 55.3%), with a sensitivity of 83%, specificity of 39%, PLR of 1.4, NLR of 0.43, and DOR of 3.
  • Low serum 25-OHD was associated with higher mortality (OR = 3.08 [1.35, 7.00], p = 0.011; I2: 80.3%), with a sensitivity of 85%, specificity of 35%, PLR of 1.3, NLR of 0.44, and DOR of 3.

Meta-regression analysis showed that the association between low serum 25-OHD and mortality was affected by male gender (OR = 1.22 [1.08, 1.39], p = 0.002), diabetes (OR = 0.88 [0.79, 0.98], p = 0.019).

Conclusion: Low serum 25-OHD level was associated with COVID-19 infection, severe presentation, and mortality.


Created by admin. Last Modification: Friday June 25, 2021 14:47:57 GMT-0000 by admin. (Version 5)

Attached files

ID Name Comment Uploaded Size Downloads
15338 Low D mortality.jpg admin 29 Mar, 2021 18:00 46.09 Kb 551
15337 Meta March 29.pdf PDF 2021 admin 29 Mar, 2021 18:00 1.84 Mb 63
See any problem with this page? Report it (FINALLY WORKS)